Cefoxitin is a Intravenous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Fresenius Kabi Usa, Llc. The primary component is Cefoxitin Sodium.
| Product ID | 63323-343_924ce0b3-fa14-62a3-e053-2995a90a15a4 |
| NDC | 63323-343 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Cefoxitin |
| Generic Name | Cefoxitin |
| Dosage Form | Injection, Powder, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2012-02-21 |
| Marketing End Date | 2019-10-31 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA065415 |
| Labeler Name | Fresenius Kabi USA, LLC |
| Substance Name | CEFOXITIN SODIUM |
| Active Ingredient Strength | 10 g/1 |
| Pharm Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [CS] |
| NDC Exclude Flag | N |
| Marketing Start Date | 2012-02-21 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA065415 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2012-02-21 |
| Marketing End Date | 2019-10-31 |
| Ingredient | Strength |
|---|---|
| CEFOXITIN SODIUM | 10 g/1 |
| SPL SET ID: | 7ae80b51-b62d-4adf-be6a-9d320cd97c76 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0143-9876 | Cefoxitin | Cefoxitin |
| 0143-9877 | Cefoxitin | Cefoxitin |
| 0143-9878 | Cefoxitin | Cefoxitin |
| 25021-109 | Cefoxitin | cefoxitin |
| 25021-110 | Cefoxitin | cefoxitin |
| 25021-111 | Cefoxitin | cefoxitin |
| 44567-245 | Cefoxitin | Cefoxitin |
| 44567-246 | Cefoxitin | Cefoxitin |
| 44567-247 | Cefoxitin | Cefoxitin |
| 60505-0759 | Cefoxitin | CEFOXITIN |
| 60505-0760 | Cefoxitin | CEFOXITIN |
| 60505-0761 | Cefoxitin | CEFOXITIN |
| 63323-341 | Cefoxitin | Cefoxitin Sodium |
| 63323-342 | Cefoxitin | Cefoxitin Sodium |
| 63323-343 | Cefoxitin | Cefoxitin |
| 66288-4100 | Cefoxitin | Cefoxitin |